Literature DB >> 27838366

The Modern Metabolic Stone Evaluation in Children.

Mark Bevill1, Ambika Kattula1, Christopher S Cooper1, Douglas W Storm2.   

Abstract

OBJECTIVE: To evaluate metabolic abnormalities in a contemporary pediatric population after their first stone episode. The incidence of pediatric nephrolithiasis is increasing and therefore the etiologies contributing to today's pediatric stone formation may also be changing.
MATERIALS AND METHODS: A retrospective review of all consecutive children presenting after their first kidney stone between 2000 and 2014 was performed. We compared demographic data, serum chemistry results, and 24-hour urine results and treatments.
RESULTS: One hundred thirteen children with a mean age of 11 years (5 months to 18 years) who presented with their first kidney stone episode between 2000 and 2014 were evaluated. Sixteen patients (14%) were found to have an underlying genetic or systemic disease. Overall, there was a low rate of serum chemistry abnormalities. The most common abnormalities found within the 24-hour urine evaluation included low urine volume (89%) and hypocitraturia (68%). Hypercalciuria occurred rarely (11%).
CONCLUSION: We identified a low rate of underlying genetic or systemic diseases contributing to modern pediatric stone presentation and an increased proportion of idiopathic stones. Our study differs from historical findings by identifying a low rate of hypercalciuria and a high rate of low urine volume and hypocitraturia, suggestive of changing metabolic abnormalities contributing to modern pediatric stone disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27838366     DOI: 10.1016/j.urology.2016.09.058

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study.

Authors:  Vidar O Edvardsson; Solborg E Ingvarsdottir; Runolfur Palsson; Olafur S Indridason
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.714

Review 2.  Drug-Induced Urolithiasis in Pediatric Patients.

Authors:  Maria Chiara Sighinolfi; Ahmed Eissa; Luigi Bevilacqua; Ahmed Zoeir; Silvia Ciarlariello; Elena Morini; Stefano Puliatti; Viviana Durante; Pier Luca Ceccarelli; Salvatore Micali; Giampaolo Bianchi; Bernardo Rocco
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

3.  Roundup.

Authors:  Santosh Kumar
Journal:  Indian J Urol       Date:  2017 Apr-Jun

Review 4.  Novel methionyl-tRNA synthetase gene variants/phenotypes in interstitial lung and liver disease: A case report and review of literature.

Authors:  Kuerbanjiang Abuduxikuer; Jia-Yan Feng; Yi Lu; Xin-Bao Xie; Lian Chen; Jian-She Wang
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742

5.  Elevated non-high-density lipoprotein cholesterol corresponds to a high risk of nephrolithiasis in children.

Authors:  Meiyuan Chen; Jing Xiao; Yuan Du; Miaomiao Wang; Jimeng Ruan; Ye Tian
Journal:  BMC Urol       Date:  2020-08-10       Impact factor: 2.264

6.  Metabolomics analysis of the serum from children with urolithiasis using UPLC-MS.

Authors:  Junxiang Wen; Yinyin Cao; Yang Li; Fenhua Zhu; Meifen Yuan; Jin Xu; Jian Li
Journal:  Clin Transl Sci       Date:  2021-02-13       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.